CD4 and neoplasm: Among the high salt activated CD4+T cell treated cohorts, CD4+T cells obtained from DLNs demonstrated significantly reduced tumor growth (day 45, high salt: 97 ± 24 mm3 vs. mannitol: 292 ± 46 mm3, p < 0.05).